|
|
|
Event Videos
|
https://pubmed.ncbi.nlm.nih.gov/36828986/ NAFLD J Endocrinol Invest. 2023 Feb 24. Association between non-alcoholic fatty liver disease and subclinical hypothyroidism in children with obesity A Di Sessa 1, N Cembalo Sambiase Sanseverino 2, R F De Simone 2, M M Marrapodi 2, G Cirillo 2, G R Umano 2, S Guarino 2, A Papparella 2, E Miraglia Del Giudice 2, P Marzuillo 2 Abstract Published on:
Feb-2023
|
https://pubmed.ncbi.nlm.nih.gov/36800295/ J Pediatr Gastroenterol Nutr. 2023 Feb 20;e003744. Accuracy and Precision of Point-of-Care International Normalized Ratio in Patients with Liver Disease Tevyn Shadlyn 1, Mary Bauman 2, Puneeta Tandon 3, Jason Yap 4, Patricia Kawada 5 Abstract Published on:
Feb-2023
|
|
https://pubmed.ncbi.nlm.nih.gov/36828986/ NAFLD J Endocrinol Invest. 2023 Feb 24. Association between non-alcoholic fatty liver disease and subclinical hypothyroidism in children with obesity A Di Sessa 1, N Cembalo Sambiase Sanseverino 2, R F De Simone 2, M M Marrapodi 2, G Cirillo 2, G R Umano 2, S Guarino 2, A Papparella 2, E Miraglia Del Giudice 2, P Marzuillo 2 Abstract Published on:
Feb-2023
|
https://pubmed.ncbi.nlm.nih.gov/36645229/ Biliary atresia Hepatology. 2023 Jan 3. Liver-restricted deletion of the biliary atresia candidate gene Pkd1l1 causes bile duct dysmorphogenesis and ciliopathy. Dominick J Hellen 1, Ashley Bennett, Sudarshan Malla, Caroline Klindt, Anuradha Rao, Paul A Dawson, Saul J Karpen Abstract Background and aims: A recent multicenter genetic exploration of the biliary atresia splenic malformation syndrome identified mutations in the ciliary gene PKD1L1 as candidate etiologic contributors. We hypothesized that deletion of Pkd1l1 in developing hepatoblasts would lead to cholangiopathy in mice. Published on:
Jan-2023
|
|
https://pubmed.ncbi.nlm.nih.gov/36822480/ Acute liver failure J Hepatol. 2023 Feb 21;S0168-8278(23)00101-0. Outbreak of indeterminate acute liver failure in children with adenoviraemia - Not a new disease Barath Jagadisan 1, Anita Verma 2, Maesha Deheragoda 3, Akash Deep 4, Tassos Grammatikopoulos 5, Malur Sudhanva 6, Sanjay Bansal 7, Nedim Hadzic 8, Sunitha Vimalesvaran 9, Nigel Heaton 10, Anil Dhawan 11 Abstract Published on:
Feb-2023
|
https://pubmed.ncbi.nlm.nih.gov/36675276/ Review Int J Mol Sci. 2023 Jan 16;24(2):1764. Abstract Published on:
Jan-2023
|
|
https://pubmed.ncbi.nlm.nih.gov/36816379/ Cholangitis Front Pediatr. 2023 Feb 3;11:1094895. Neonatal sclerosing cholangitis with novel mutations in DCDC2 (doublecortin domain-containing protein 2) in Chinese children Xia Wei 1, Yuan Fang 1, Jian-She Wang 2, Yi-Zhen Wang 1, Yuan Zhang 3, Kuerbanjiang Abuduxikuer 2, Lian Chen 4 Abstract Background: Neonatal sclerosing cholangitis (NSC) is a rare and severe autosomal recessive inherited liver disease with mutations in DCDC2, commonly requiring liver transplantation (LT) for decompensated biliary cirrhosis in childhood. Published on:
Feb-2023
|
https://pubmed.ncbi.nlm.nih.gov/36675485/ NAFLD J Clin Med. 2023 Jan 10;12(2):557. The Burden of Non-Alcoholic Fatty Liver Disease in Adolescents with Polycystic Ovary Syndrome: A Case-Control Study Aikaterini Giannouli 1, Vasiliki Efthymiou 1, Marianna Konidari 2, Iliana Mani 3, Leon Aravantinos 4, Spyridon P Dourakis 3, Aristeidis Antoniou 2, Efthymios Deligeoroglou 5, Flora Bacopoulou 1 Abstract Published on:
Jan-2023
|
|
https://pubmed.ncbi.nlm.nih.gov/36816376/ Metabolic liver disease Front Pediatr. 2023 Feb 3;11:1084336. Clinical features and enzyme replacement therapy in 10 children with Fabry disease Qian Li 1 2, Jing Wang 1 2, Minle Tian 3, Zhenle Yang 1 2, Lichun Yu 1 2, Suwen Liu 1 2, Cong Wang 1 2, Xiaoyuan Wang 1 2, Shuzhen Sun 1 2 Abstract Objective: To summarize the clinical features, diagnosis and enzyme replacement therapy(ERT) of Fabry disease (FD) in children. Published on:
Feb-2023
|
https://pubmed.ncbi.nlm.nih.gov/36692476/ Biliary atresia Hepatology. 2023 Jan 3. doi: 10.1097/HEP.0000000000000048. Online ahead of print. Serum FGF19 predicts outcomes of Kasai portoenterostomy in biliary atresia. Iiris Nyholm 1 2, Maria Hukkinen 1 2, Marjut Pihlajoki 1, Joseph R Davidson 3 4, Athanasios Tyraskis 4, Jouko Lohi 5, Päivi Heikkilä 5, Satu Hänninen 5, Noora Andersson 5, Katja Eloranta 1, Olli Carpén 5, Markku Heikinheimo 1 6, Mark Davenport 4, Mikko P Pakarinen 1 2 7 Abstract Background and aims: Outcomes after Kasai portoenterostomy (KPE) for biliary atresia remain highly variable for unclear reasons. As reliable early biomarkers predicting KPE outcomes are lacking, we studied the prognostic value of FGF19. Published on:
Jan-2023
|
SMS requests to
9224791366
Ask The Expert
Pediatric Liver Specialists in India
Centres offering Genetic Testing for Pediatric Liver Diseases
Financial Aid Offered by Trusts
